A Trial to Evaluate the Safety and Efficacy of Elamipretide in Subjects With Primary Mitochondrial Myopathy Followed by an Open-Label…The purpose of this study is to evaluate the safety and efficacy of daily subcutaneous injections of elamipretide in subjects with primary mitochondrial myopathy. Recruiting Principal Investigator Anna LehmanBody Locations and Systems Muscles, Neuromuscular DisordersArea VancouverAge 16-80
